Why is Biohaven Ltd. stock down today?
September 23, 2026
Biohaven Ltd.
BHVN · NYQ · USD
vs. prev. close $14.85
Last updated Sep 23, 2026 16:45
Intraday Chart — 5-min intervals
BHVN · less than a minute ago
Biohaven Ltd. falls 8.01% as Barrons.com weighs on sentiment
The news backdrop is active, led by "Xenon Stock Craters 30% on Drug Trial Setback. Its Failure Could Be This Biotech’s Gain." and "Warby Parker’s Unusual Options Activity Points to a Covered Call Bet: Bullish on Growth, Cautious on Valuation"; the headline mix is leaning mixed. BHVN is showing a 8.01% decline today, putting the latest price near $13.66.
Across major indices, S&P 500: -0.7%, Nasdaq: -1.2%, Dow Jones: -0.6%, Shanghai: -0.3%, Hang Seng: -0.8%; that puts the market backdrop in a under pressure state.
The setup can change quickly as new filings, headlines, and market data arrive.
Key Factors
Auto-generated analysis · Not financial advice

Xenon Stock Craters 30% on Drug Trial Setback. Its Failure Could Be This Biotech’s Gain.
Barrons.com·5 days agoneutral
Warby Parker’s Unusual Options Activity Points to a Covered Call Bet: Bullish on Growth, Cautious on Valuation
Barchart·5 days agoneutralBiohaven's Kv7 Program Remains Key Stock Driver, UBS Says
MT Newswires·5 days agoneutral
Biohaven’s epilepsy drug hit with FDA clinical hold
Clinical Trials Arena·12 days agoneutral
Biohaven Plummets, A Boon For Rival Xenon, On A Surprise Seizure Setback
Investor's Business Daily·13 days agoneutral
Biohaven Stock Is Sinking. Epilepsy Drug Trial Roadblock Is Only the Latest Blow.
Barrons.com·13 days agoneutral
Biohaven Shares Fall 17% After FDA Places Partial Hold on BHV-7000 Trials
InvestorsHub·13 days agoneutralBHVN Stock Crashes 10% – Why Did FDA Put Biohaven’s Epilepsy Trial On Partial Hold?
Stocktwits·13 days agoneutral
S&P 500
-0.71%
Nasdaq
-1.18%
Dow Jones
-0.58%
Shanghai
-0.34%
Hang Seng
-0.83%
Nikkei 225
+1.38%
FTSE 100
-0.03%
Nifty 50
+0.14%
DAX
-0.66%
OMX Stockholm
-0.57%
Search another stock